FDA panel backs HeartWare blood pump
This article was originally published in Clinica
Executive Summary
HeartWare's implantable blood pump has won the support of an FDA advisory panel, allaying concerns that study data linking a higher-than-average stroke risk to the device would scupper the product's chances of gaining premarket approval.